The Use of Temozolomide for the Treatment of Malignant Tumors: Clinical Evidence and Molecular Mechanisms of Action

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|5|3|172-187

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.5, Iss.3, 2010-01, pp. : 172-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temozolomide: A Review of its Use in the Treatment of Malignant Gliomas, Malignant Melanoma and Other Advanced Cancers

By Darkes M.J.M.   Plosker G.L.   Jarvis B.  

American Journal of Cancer, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-80

Adis International

Access to resources Recommend Favorite

Mechanisms of coagulative necrosis in malignant epithelial tumors (Review)

By              

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1397-1402

Spandidos Publications

Access to resources Recommend Favorite

The clinical pathological features, diagnosis, treatment and prognosis of small intestine primary malignant tumors

By Guo Xiaochuan   Mao Zhiyuan   Su Dan   Jiang Zhaocai   Bai Li  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-12

Humana Press, Inc

Access to resources Recommend Favorite

Clinical research on zoledronic acid in treatment of pain caused by bone metastasis of malignant tumors

By Yu Zhuang   Liang Jun   Peng Ling  

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 4, 2007-08 ,pp. : 399-401

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors

By Ruggiero Antonio  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 513-518

Springer Publishing Company

Access to resources Recommend Favorite